反应器市场规模、份额和成长分析（按材料、使用阶段、控制方法和地区）：产业预测（2024-2031）

2022年全球反应器市场规模约为135万美元，从2023年的146万美元成长到2031年的268万美元，并在预测期内（2024-2031年）成长790万美元。为%。

由于製药和生物製药领域的使用增加，全球反应器市场正在经历强劲成长。反应器在推进研究和开发过程中发挥重要作用，特别是在受控条件下培养用于治疗慢性疾病的生物体。对单株抗体的需求不断增长以及政府对疫苗生产的资助进一步推动了市场扩张。此外，一次性反应器的日益普及对产生收入做出了重大贡献，反映出该行业正在转向经济高效且灵活的解决方案。技术进步增强了反应器的能力，并实现了可提高效率和结果的创新功能。不断扩大的製药和生物技术行业以及私营组织不断增加的投资，使得从药物开发到工业生产等广泛应用对反应器的依赖日益增加。透过这种方式，反应器被定位为解决世界各地医疗问题不可或缺的工具，并正在推动市场成长。

目录

介绍

• 分析目的
• 定义
• 市场范围

分析方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 创新矩阵
• 监管分析
• 案例研究分析
• 技术分析
• 专利分析

反应器市场：依材料分类

• 市场概况
• 玻璃
• 不銹钢
• 一次性型（一次性使用）
• 其他的

反应器市场：按规模

• 市场概况
• 5～20L
• 20～200L
• 200～1500L
• 1500L以上

反应器市场：依应用分类

• 市场概况
• 抗体
• 疫苗
• 细胞疗法
• 其他的

反应器市场：依使用阶段划分

• 市场概况
• 试验生产
• 试生产
• 全面生产
• 其他的

反应器市场：依控制方法分类

• 市场概况
• 手动的
• 自动化（MFC）

反应器市场：依供应商分类

• 市场概况
• OEM
• 系统整合商
• EPC（设计、采购、施工）

反应器市场：依最终用户分类

• 市场概况
• 研发机构
• CRO（药物委外研发机构）
• 生物製药製造商
• 其他的

反应器市场：按地区分類的规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（%，2023年）

主要企业简介

• 赛多利斯股份公司（德国）
• 赛默飞世尔科技公司（美国）
• 通用电气（美国）
• 艾本德股份公司（德国）
• 默克公司（德国）
• 颇尔公司（美国）
• ZETA（印度）
• PRaj Hippurity Systems Limited（印度）
• 生物工程股份公司（瑞士）
• Infors AG（瑞士）
• Solaris Biotechnology Srl.（唐纳森公司）（义大利）
• Bbi生物技术（德国）
• 上海百伦生物科技有限公司 (中国)
• PBS Biotech Inc.（美国）
• CerCell A/S（丹麦）
• GEA 集团股份公司（德国）
• M+W 集团（德国）
• 德希尼布公司（法国）
• 雅各布斯工程集团公司（美国）

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024-2031).

The global bioreactors market is experiencing robust growth, driven by their increasing use in the pharmaceutical and biopharmaceutical sectors. Bioreactors play a critical role in advancing procedures for research and development, particularly in cultivating organisms used to treat chronic illnesses under controlled conditions. The rising demand for monoclonal antibodies and government-backed funding for vaccine production further fuel market expansion. Additionally, the growing adoption of single-use bioreactors significantly contributes to revenue generation, reflecting the industry's shift toward cost-effective and flexible solutions. Technological advancements have enhanced bioreactor capabilities, enabling innovative features that improve efficiency and outcomes. The expanding pharmaceutical and biotechnology industries, coupled with rising investments from private organizations, underscore the growing reliance on bioreactors for diverse applications, from drug development to industrial processes. This convergence of factors positions bioreactors as essential tools in addressing global healthcare challenges while driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioreactors Market Segmental Analysis

Global Bioreactors Market is segmented by Materials, Scale, Usage, Application, Control Type, Suppliers, End-Users and region. Based on Materials, the market is segmented into Glass, Stainless Steel, Single-Use, and Others. Based on Scale, the market is segmented into 5L-20L, 20L-200L, 200L-1500L, and Above 1500L. Based on Application, the market is segmented into Antibodies, Vaccines, Cell Therapies, Others. Based on Usage, the market is segmented into Lab-Scale Production, Pilot-Scale Production, Full-Scale Production, and Others. Based on Control Type, the market is segmented into Manual, and Automated (MFCs). Based on Suppliers, the market is segmented into OEMs (Original Equipment Manufacturers), System Integrators, EPCs (Engineering Procurement and Construction). Based on End User, the market is segmented into R&D Institutes, Contract Research Organizations, Biopharmaceutical Manufacturers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bioreactors Market

The increasing utilization of bioreactors for manufacturing various vaccines, which play a crucial role in mitigating numerous diseases, is significantly driving the growth of the global bioreactors market. The recent outbreak of the COVID-19 pandemic highlighted the critical need for effective vaccine production, leading to a surge in demand for clinical-stage bioreactors. Pharmaceutical companies extensively adopted bioreactors to meet the heightened demand and successfully deliver preventive vaccines to the market. This trend underscores the pivotal role of bioreactors in accelerating vaccine development and production processes, making them indispensable for combating existing and emerging health crises. As a result, the market is witnessing robust growth driven by advancements in bioprocessing technologies and the urgent need for scalable solutions in vaccine manufacturing.

Restraints in the Global Bioreactors Market

The global bioreactors market faces a significant restraint due to the limitations of single-use bioreactors. Despite the availability of various bioreactor types, single-use bioreactors are hindered by their limited capacity and inability to support prolonged operations. These constraints pose substantial challenges, particularly in processes requiring high scalability and extended durations, making them less viable for pharmaceutical and biopharmaceutical companies. Consequently, the adoption of single-use bioreactors has been adversely affected, creating a bottleneck in the market's growth. This limitation highlights the need for advanced bioreactor technologies capable of addressing these challenges while maintaining the benefits of single-use systems, such as cost efficiency and flexibility, to enable broader market expansion.

Market Trends of the Global Bioreactors Market

The global bioreactors market is witnessing significant growth driven by continuous innovations in bioreactor design and processing technologies. Manufacturers are actively developing advanced, cost-efficient bioreactors that enable the large-scale production of various products, enhancing operational efficiency and reducing costs. These technological advancements not only improve bioprocessing capabilities but also offer several advantages, such as higher productivity and streamlined processes, further boosting market demand. The integration of cutting-edge features in bioreactors is contributing to increased adoption across industries, resulting in higher revenue generation and market expansion. This trend underscores the pivotal role of technology in shaping the future of the bioreactors market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Innovation Matrix
• Regulatory Analysis
• Case Study Analysis
• Technology Analysis
• Patent Analysis

Bioreactor Market, By Materials

• Market Overview
• Glass
• Stainless Steel
• Single-Use
• Others

Bioreactor Market, By Scale

• Market Overview
• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L

Bioreactor Market, By Application

• Market Overview
• Antibodies
• Vaccines
• Cell Therapies
• Others

Bioreactor Market, By Usage

• Market Overview
• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production
• Others

Bioreactor Market, By Control Type

• Market Overview
• Manual
• Automated (MFCs)

Bioreactor Market, By Suppliers

• Market Overview
• OEMs (Original Equipment Manufacturers)
• System Integrators
• EPCs (Engineering Procurement and Construction)

Bioreactor Market, By End User

• Market Overview
• R&D Institutes
• Contract Research Organizations
• Biopharmaceutical Manufacturers
• Others

Bioreactor Market, Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pall Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZETA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRaj Hipurity Systems Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioengineering AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infors AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solaris Biotechnology Srl. (Donaldson Company) (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bbi Biotech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Bailun Biotechnology co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PBS Biotech Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CerCell A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GEA Group Aktiengesellschaft (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• M+W Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Technip S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jacobs Engineering Group Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments